Treatment of traumatic myositis ossificans circumscripta; use of aspiration and steroids.
The classification, clinical presentation, forms of treatment, and theories of pathogenesis of traumatic myositis ossificans circumscripta are reviewed. A group of 7 patients with this lesion was treated with hematoma aspiration and injection of steroids, lysosomal enzymes, and xylocaine, resulting in significant limitation of disability. The determining factor in the development of this disorder seems to be the response of local soft tissues to trauma rather than the magnitude of the trauma itself which we feel accounts for the success of the form of treatment described.
D000293:Adolescent; D001134:Arm Injuries / Q000150:complications; D001265:Athletic Injuries / Q000150:complications*; D003348:Cortisone / Q000627:therapeutic use; D003907:Dexamethasone / Q000627:therapeutic use; D006406:Hematoma / Q000628:therapy; D006801:Humans; D006821:Hyaluronoglucosaminidase / Q000627:therapeutic use; D007869:Leg Injuries / Q000150:complications; D008297:Male; D008875:Middle Aged; D009221:Myositis Ossificans / Q000209:etiology / Q000628:therapy*; D013396:Suction
D003907:Dexamethasone; D006821:Hyaluronoglucosaminidase; D003348:Cortisone